Compare Rex Fang & Innovation Equity Premium Income ETF (FEPI) vs Tempus AI (TEM) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Rex Fang & Innovation Equity Premium Income ETF vs Tempus AI — how do they compare? Rex Fang & Innovation Equity Premium Income ETF trades at $43.36 (market cap $740.04M), while Tempus AI trades at $69.99 (market cap $12.77B). The key difference: Tempus AI is far larger — about 17.3× Rex Fang & Innovation Equity Premium Income ETF's market cap, and Rex Fang & Innovation Equity Premium Income ETF is more actively traded (227,930 versus 8,980,490). Which is the better fit depends on your goals — on Pluang, investors hold Rex Fang & Innovation Equity Premium Income ETF for 56 Days and Tempus AI for 22 Days on average.
| FEPI | TEM | |
|---|---|---|
Market Cap | $740.04M | $12.77B |
Volume | 227,930 | 8,980,490 |
Sector | Income / Options Overlay | Broad Market / Factor |
52-Week High | $49.54 | $99.28 |
52-Week Low | $37.98 | $41.55 |
Typical Hold Time | 56 Days | 22 Days |
Enterprise Value | — | $13.40B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
FEPI (REX FANG & Innovation Equity Premium Income ETF) trades at $43.59, showing minimal daily movement with a -0.17% decline. The ETF employs a covered call strategy on AI and mega-cap tech stocks, generating substantial weekly dividends averaging $0.20-0.21 per distribution. Technical indicators show a bullish trend with strong moving average support, though RSI levels suggest potential overbought conditions. Recent news highlights FEPI's 25% yield but questions its total return performance compared to peers.
FEPI offers high income generation through its covered call strategy but faces challenges in capital appreciation and drawdown protection. The concentrated tech exposure creates volatility risk, particularly if AI momentum slows. While the weekly dividend structure appeals to income investors, the capped upside and elevated risk profile warrant caution for total return seekers.
Tempus AI (TEM) trades at $70.29, down 2.35% on the day, with a bullish technical signal despite negative profitability. Recent FDA clearance for its ECG-MR AI product and 13 abstracts accepted for ESMO Congress 2026 highlight ongoing innovation. Revenue grew to $1.4B in 2026, though net losses persist. The stock shows strong analyst support with a $72.60 consensus target and 64% buy ratings.
Outlook remains cautiously optimistic driven by AI healthcare adoption and data licensing growth, but high valuation multiples and sustained losses pose risks. Investor sentiment is positive amid recent insider selling and institutional interest, yet profitability challenges and competitive pressures require monitoring for long-term value creation.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
About Rex Fang & Innovation Equity Premium Income ETF
FEPI provides exposure to top innovation stocks while generating monthly income. It uses a covered call strategy on high-volatility tech stocks to capture option premiums for investors.
Read more on FEPI →About Tempus AI
Tempus AI Inc is a technology company. It has built the Tempus Platform, which comprises both a technology platform to free healthcare data from silos and an operating system to make the resulting data useful. Its Intelligent Diagnostics use AI, including generative AI, to make laboratory tests more accurate, tailored, and personal.
Read more on TEM →
